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Molecularly imprinted polymers for the extraction of
imiquimod from biological samples using a template
analogue strategy
Panagiotis Manesiotis,*a Sakina Kashanib and Peter McLoughlinb
Molecularly Imprinted Polymers (MIPs) against imiquimod, a highly potent immune responsemodiﬁer used
in the treatment of skin cancer, were synthesised using a template analogue strategy and were compared
with imprints of the drug itself. An investigation of the complexation between the functional monomer
and the template analogue revealed an association constant of 1376  122 M1, signiﬁcantly higher
than previously reported values for similar systems. The binding characteristics of the synthesised
imprinted polymers were evaluated and extremely strong binding for imiquimod was observed while
imprinting factors as high as 17 were calculated. When applied as sorbents in solid-phase extraction of
imiquimod from aqueous, urine and blood serum samples, clean extracts and recoveries up to 95%
were achieved, and it is concluded that while imiquimod imprints exhibited higher capacity for the
drug, template analogue imprints are more selective. The results obtained suggest potential applications
of imiquimod imprints as sorbents in rapid extraction and monitoring of undesirable systemic release of
the drug.
1 Introduction
Molecularly imprinted polymers are synthetic materials that
contain specic binding sites, complementary to a compound
of interest in terms of size, shape and functional group orien-
tation.1–3 Such imprinted sites are generated by locking in place
solution complexes between the template of interest and a
complementary functional monomer, by co-polymerising these
complexes with an excess of a cross-linking monomer. Upon
completion of the polymerisation reaction, the removal of the
template reveals the specic binding sites that are then able to
reversibly rebind the template or closely related substances and,
depending on the application in hand, extract it from a
complicated sample matrix (MI-SPE),4 resolve enantiomeric
forms in a racemic mixture of chiral compounds (MI-CSP)5 or
signal the binding event acting as a sensing element.6
The requirement of a template or a mould around which the
molecularly imprinted polymer will be built can in some cases
be a limiting factor, as quite oen the targeted compound can
be prohibitively expensive, incompatible with the polymerisa-
tion protocol, e.g. heat or light sensitive, insoluble in polymer-
isation solvents of choice, dangerous to the researchers' health
or simply unavailable. In such cases scientists have employed
template substitutes or “dummy” templates, as they are oen
called, whereby a compound of closely related structure to the
substance of interest is imprinted instead of the actual target
itself. The resulting polymers have been shown to exhibit
excellent recognition properties not only for the substitute
template, but also for the actual target, largely depending on the
similarity of the chosen template to the targeted structure.7–9
9-Ethyladenine is a typical example of such a template, used by
Spivak et al. as an organic solvent soluble analogue of adenine
in the study of nucleotide base imprinted polymers.10–12
In the present report, our aim was to develop molecularly
imprinted polymers that will enable selective separation and
quantitation of imiquimod (IMQ), a highly potent prescribed
medication that acts as an immune response modier. Imi-
quimod was approved by the FDA for treatment of various types
of skin cancer, as well as genital warts, in 1997, and it is
formulated as a 5% patient-applied cream under the trade
name Aldara (3M Healthcare). Although imiquimod is
applied topically, a systemic release of the drug is known to
occur, with severe side-eﬀects reported in some patient
cases.13,14 Thus, a rapid and robust method for isolation and
pre-concentration of imiquimod from biological uids could be
an invaluable tool in early detection of systemic release and
curtailment of its impact on patient well-being.
Imiquimod is sparingly soluble in organic or aqueous
solvents at neutral pH. This poses an immediate limitation to
the development of an imprinting protocol, hence a template
analogue strategy was originally chosen. However, based on the
observation that the drug is more soluble in acidic
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environments, it was possible to reach the desirable concen-
tration by slight modication of the pre-polymerisation solu-
tion composition and thus prepare an imiquimod imprinted
polymer, whose performance was subsequently compared to
the template analogue based material.
2 Experimental
2.1 Materials and methods
Ethyleneglycol dimethacrylate (EDMA), methacrylic acid (MAA),
1,10-azobis(cyclohexanecarbonitrile) (ACCN), adenine, thymine,
cytosine, uracil, 5-uorouracil, 1-bromo-2-methylpropane,
potassium carbonate, HPLC grade solvents, CDCl3, DMSO-d6,
and anhydrous N,N-dimethylformamide (DMF) were purchased
from Sigma-Aldrich (Wicklow, Ireland). Imiquimod was a
donation from EirGen Pharma (Waterford, Ireland). Water was
puried by a SG Ultra Clear TWF UV Plus TM water purication
system (Whitewater, Blackrock, Ireland). EDMA was puried by
extraction with 10% NaOH, washing with brine, drying over
anhydrous magnesium sulphate, and subsequent distillation
under reduced pressure. MAA was distilled under reduced
pressure.
NMR spectra were obtained using a Jeol ECX 400 spectrom-
eter (Tokyo, Japan). HPLCmeasurements were performed using
an Agilent 1200 system equipped with a diode array detector.
Surface area analysis was performed using a Micromeritics
Gemini VI Nitrogen sorption analyser (Particular Sciences,
Dublin, Ireland).
2.2 Template analogue synthesis
The template analogue, 9-isobutyladenine (9IBA), was syn-
thesised using a protocol previously described,15 adapted as
follows: 2.6 g (20mmol) of adenine were suspended in 100mL of
anhydrous DMF and 3.5 g (25 mmol) of K2CO3 were added. The
mixture was stirred at room temperature for 24 h in order to
form the potassium salt of adenine. Then, 3.4 g (25 mmol) of
1-bromo-2-methylpropane were added to the slurry mixture and
allowed to react for a further 72 h. DMF was then removed under
reduced pressure and the solid residue was suspended in water.
The aqueous layer was extracted with CHCl3 (3  50 mL), the
organic layers were combined, dried over MgSO4 and nally the
solvent was evaporated under reduced pressure to yield 9IBA as a
white solid. This was recrystallised from butan-2-one to yield the
nal product. 1H NMR (DMSO-d6): d (ppm): 0.80 (d, 6H,
–CH(CH3)2), 2.14 (m, 1H, –CH(CH3)2), 3.91 (d, 2H,
–NCH2CH(CH3)2), 7.16 (s, br, 2H, –NH2), 8.08 (s, 1H, imidazole
CH), 8.09 (s, 1H, pyrimidine CH). 13C NMR (DMSO-d6): d (ppm):
20.1, 29.0, 50.5, 119.2, 141.7, 150.3, 153.9, 156.5. LC-MS analysis:
calculated MW for C9H13N5: 191.12, found m/z: 192.1 (MH
+).
2.3 Pre-polymerisation studies
Monomer–template complexation was studied prior to polymer
synthesis by means of a 1H NMR titration in CDCl3 in order to
establish the strength of interactions present in the pre-poly-
merisation solution. Hence, to a solution of 9IBA (1 mmol L1)
were added increasing amounts of MAA. The complexation-
induced shi (CIS) of 9IBA's H2 proton was followed, and a
titration curve was then constructed. The raw titration data were
tted to a 1 : 1 binding isotherm, and the association constant
was obtained by nonlinear regression. The stoichiometry of the
9IBA–MAA complex was conrmed using Job's method of
continuous variation.16 Hence, equimolar solutions (10 mmol
L1) of 9IBA and MAA were mixed in diﬀerent ratios and a plot
of Dd against the molar fraction of 9IBA multiplied by the CIS
(X9IBA  Dd) was constructed.
2.4 Preparation of imprinted polymers
9IBA imprinted polymers (9IBA-MIP) were synthesised using a
4 : 1 ratio of functional monomer (MAA) to template plus 20
equivalents of the cross-linker (EDMA). Thus, 0.191 g (1 mmol) of
9IBA and 0.342 mL (4 mmol) of MAA were dissolved in 5.6 mL of
acetonitrile followed by addition of 4 g (20 mmol) of EDMA in a
20 mL screw-cap vial. The solution was degassed using N2 while
cooling in an ice-bath for 5 minutes. Finally, 0.04 g of the free
radical initiator ACCN were added and the vial was sealed and
placed in a UV reactor at 4 C for 24 hours. Imiquimod imprinted
polymers (IMQ-MIP) were prepared in the same manner however,
a total of 7 mmol of MAA were required in order to dissolve the
drug in the pre-polymerisationmixture, resulting in a 7 : 1 ratio of
MAA : IMQ. In both cases, the corresponding non-imprinted
polymers (9IBA-NIP and IMQ-NIP) were synthesised with omis-
sion of the template. The resulting monoliths were smashed to
coarse particles and washed with methanol for 24 hours using a
Soxhlet apparatus. Finally, the polymers were manually ground
and sieved collecting the 25–38 mm fraction for packing intoHPLC
columns and SPE cartridges.
2.5 Chromatographic evaluation
Imprinted or non-imprinted particles of 25–38 mm were slurry
packed in 50 mm  4.6 mm i.d. HPLC columns using a 4 : 1
methanol : water mixture. The columns were then connected to a
HPLC instrument and equilibrated with CH3CN–1% CH3COOH
until a stable baseline was obtained. Analyses were performed at
1 mL min1 by injecting 5 mL of a 1 mmol L1 solution of each
analyte and recording its elution prole at 240 or 260 nm. All
injections were repeated at least three times, alternating between
the diﬀerent analytes to avoid column overloading.
Staircase frontal chromatography was performed on 9IBA-
MIP and 9IBA-NIP using solutions of 9IBA in CH3CN–1%
CH3COOH as the mobile phase and mixing them in a step-wise
fashion of 10% increments with the pure mobile phase to
produce a staircase frontal chromatogram with a total of 30
steps in the concentration range 106 to 103 mol L1. From
each step the corresponding amount of bound analyte was
calculated and the collected results were plotted against the
corresponding concentration of 9IBA to produce binding
isotherms that were tted using the appropriate binding model.
2.6 Solid phase extractions
25 mg of MIP and NIP particles were dry packed in 3 mL SPE
cartridges using 20 mm porous PTFE frits. Equilibration of the
columns, loading andwashing were performed using 1mL aliquot
This journal is ª The Royal Society of Chemistry 2013 Anal. Methods, 2013, 5, 3122–3128 | 3123
Paper Analytical Methods
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
3 
A
pr
il 
20
13
. D
ow
nl
oa
de
d 
on
 0
3/
10
/2
01
5 
11
:0
3:
36
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
of the corresponding solutions and elution of the retained analytes
was achieved with 1 mL of CH3OH–5% CH3COOH. Full vacuum
was applied between each step for 3 minutes in order to dry the
stationary phases. The collected fractions were analysed by HPLC
using a 150mm 3.9mm, 5 mmC18 column and isocratic elution
using amixture of CH3CN : aqueous CH3COONa (10mM, pH¼ 4)
40 : 60 with the ow-rate set at 1 mL min1. Under these condi-
tions imiquimod eluted at 3.9minutes. Blood serum samples were
prepared by allowing the collected blood to clot at room temper-
ature for approximately 45 minutes, followed by centrifugation at
3000 rpm for 15 minutes, and careful collection of the clear top
layer. Serum samples were stored at80 C. SPE analysis of serum
samples was performed on spiked samples (10 mg mL1) aer
dilution with ultra-pure water. Urine samples were ltered, spiked
and analysed following dilution with ultra-pure water. The
protocol for biological sample analysis was approved by the
Institutional Ethics Committee and written consent was obtained.
3 Results and discussion
3.1 Choice of the template analogue
Given the limited solubility of imiquimod in the organic
solvents commonly used in molecular imprinting it was origi-
nally decided to follow a template analogue approach. Upon
examination of the drug's structure, it is noticeable that its core
ring structure bears signicant similarities to that of adenine. It
was thus proposed that substitution of the N9-position of the
DNA base with an isobutyl group could serve a dual purpose:
enhance the solubility of the template analogue and, more
importantly, make the latter structurally similar to the targeted
drug (Scheme 1). Thus, 9-isobutyladenine (9IBA) was chosen as
a template analogue and synthesised in a 2-step reaction in
moderate to high yields.
3.2 Pre-polymerisation studies
The interaction between nucleic acid bases and carboxylic acids
has been previously investigated. In an early report by
Lancelot,17 butyric acid was used as an analogue of amino acid
side chain acidic functionalities and the strength as well as its
mode of interaction with the DNA bases was extensively studied
using 1H-NMR titrations in CDCl3. The ndings suggested an
association constant between butyric acid and 9-ethyladenine of
160 M1 at 303 K, while it was proposed that 3 diﬀerent
complexes contributed to the total association event. More
recently, Janke et al.18 studied the complexation of adenosine
with acetic acid using low temperature 1H NMR as well as 2D
NMR and found an association constant of 296 M1 at 293 K
between the two counterparts.
The system studied here is not very dissimilar to the ones
reported previously however it was decided to calculate the
binding constant between the specic compounds involved.
Interestingly, our ndings suggest a much stronger association
between 9IBA and methacrylic acid, and a Ka ¼ 1376  122 M1
was calculated when 9IBA's H2 was monitored (Fig. 1), almost
an order of magnitude higher than the values previously
reported. Job plot experiments veried a 1 : 1 complex stoichi-
ometry, warranting the use of a 1 : 1 binding model to t the
obtained experimental results (Fig. 1, inset).
This signicantly higher Ka value can be attributed to the fact
that methacrylic acid has diﬀerent pKa value than the carboxylic
acids used in previous studies and more importantly, to the
concentration of host (9IBA) used in this study (1 mmol L1)
compared to 20–35 mmol L1 used in previous studies. The
lower concentration used here should eliminate the inuence of
self-association of both guest and/or host molecules occurring
at higher concentrations, but also probe stronger complexation
events, occurring at low concentrations. In any case, a Ka of this
magnitude is in agreement with the ndings of fundamental
studies on MIPs, whereby exceptionally strong binding against
adenine derivatives using MAA as the functional monomer has
been reported.10,11
3.3 Chromatographic evaluation of imprinted polymers
Nitrogen sorption analysis of the synthesised polymer particles
revealed that all tested materials have a microporous character
Scheme 1 Proposed primary (black) and secondary (grey) mode of interaction
between the functional monomer (MAA) and 9IBA, and the chemical structure of
imiquimod (IMQ).
Fig. 1 1H NMR titration binding isotherm of 9IBA with MAA: experimental data
(>) and the corresponding ﬁtted curve. Inset: Job plot for the 9IBA–MAA
complex.
Table 1 Speciﬁc surface areas and pore dimensions of synthesised polymers
9IBA-MIP 9IBA-NIP IMQ-MIP IMQ-NIP
Surface area (m2 g1) 241.5 210.2 229.8 210.7
Pore volume (cm3 g1) 0.44 0.56 0.51 0.49
Pore diameter (A˚) 82.0 99.5 102.7 128.9
3124 | Anal. Methods, 2013, 5, 3122–3128 This journal is ª The Royal Society of Chemistry 2013
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with very similar specic surface areas and pore dimensions
(Table 1). Furthermore, both imprinted polymers have 10–15%
higher specic surface areas than the corresponding non-
imprinted polymers, demonstrating the inuence of the
template in the formation of the porous network. These parti-
cles were packed in 50 mm  4.6 mm HPLC columns and
connected to a HPLC instrument for chromatographic evalua-
tion. This was performed by consecutive injections of the
template (9IBA), the analyte of interest (IMQ) and the DNA and
RNA bases. 5-Fluorouracil (5-FU) was also included in the
injection series.
In agreement with the ndings of Shea et al.,19 MAA-based
MIPs against adenine derivatives exhibit extremely long reten-
tion times for their template when tested using the porogen as a
mobile phase. Thus, when 9IBA was injected on the 9IBA-MIP
column prepared here, no elution was observed aer 1.5 hours
of analysis using acetonitrile as a mobile phase. Similarly, IMQ,
adenine and cytosine were also retained for >1.5 h while
thymine, uracil and 5-FU all eluted at or near the solvent front
on both columns (data not shown). The latter observation is
attributed to the lack of complementarity between the imide
functionality of the pyrimidine bases and the donor–acceptor
hydrogen bond array of methacrylic acid.
In order to facilitate elution of the injected analytes from the
imprinted and non-imprinted columns, 1% acetic acid was
added to themobile phase, aiming to disrupt hydrogen bonding
of the analytes to the stationary phase and reduce elution times.
Indeed, under the new analysis conditions 9IBA eluted in 28
minutes while IMQ was retained for 63 minutes (Table 2). An
imprinting factor (IF ¼ kMIP/kNIP) of 17 was calculated for IMQ,
more than 2.5 times higher than the IF calculated for the
template itself (IF ¼ 6.4), supporting the design and choice of
9IBA as a template analogue. Adenine and cytosine did not elute
from the imprinted column aer 1.5 h however their retention
times on the non-imprinted column were signicantly reduced
to 10 and 6.2 minutes respectively (Fig. 2). This observation
clearly demonstrates the shape, size and functional group
complementarity of the synthesised imprinted polymer:
adenine, slightly smaller and lacking the non-functional bulky
side chain of 9IBA, is tightly bound by the binding cavities while
cytosine, much smaller but with a very similar functional group
orientation to 9IBA, is also strongly bound. Thymine, uracil and
5-FU eluted again at or near the solvent front on both columns.
HPLC evaluation of IMQ-MIP and IMQ-NIP revealed similar
binding characteristics, albeit retention times were signicantly
longer. Thus, apart from adenine and cytosine, IMQ and 9IBA
were also not eluted from the imprinted column aer 1.5 h of
analysis. Notably, retention times of IMQ-NIP were longer
compared to those of 9IBA-NIP, possibly due to the higher
amount of MAA used, contributing to an increase in non-
specic binding. This led to an overall decrease in the corre-
sponding calculated imprinting factors; nonetheless, these
values have only qualitative interest as the exact retention time
on the imprinted column could not be determined.
Overall, the two imprinted polymers exhibit similar behav-
iour towards the tested analytes with IMQ-MIP being potentially
Table 2 Retention times (tR), retention factors (k ¼ (tR  t0)/t0) and imprinting factors (IF ¼ kMIP/kNIP) of IMQ, 9IBA and structural analogues on imprinted and non-
imprinted polymer packed HPLC columns (see the Experimental section for conditions)
Analyte
tR (min) k
IF
tR (min) k
IF9IBA–MIP 9IBA–NIP 9IBA–MIP 9IBA–NIP IMQ–MIP IMQ–NIP IMQ–MIP IMQ–NIP
5-Fluorouracil 1.6 1.0 1.3 0.4 3.1 1.3 1.1 0.8 0.4 1.9
Uracil 3.8 1.3 4.3 0.8 5.5 3.9 1.3 4.2 0.7 5.8
Thymine 4.3 1.4 5.1 0.9 5.9 2.7 1.7 2.7 1.2 2.1
9IBA 28.0 5.1 38.0 5.9 6.4 >90.0 10.1 >125.0 12.2 >9.8
Imiquimod 63.0 4.5 87.0 5.1 17.0 >90.0 16.2 >125.0 20.2 >5.9
Adenine >90.0 10.0 >125.0 13.0 >9.7 >90.0 19.7 >125.0 24.8 >4.8
Cytosine >90.0 6.2 >125.0 7.6 >16.6 >90.0 11.4 >125.0 14.0 >8.6
Fig. 2 Retention times (tR, min) of imiquimod and related substances on (a) 9IBA and (b) IMQ imprinted polymer packed HPLC columns (50 mm  4.6 mm i.d.).
Conditions: mobile phase: CH3CN–1% CH3COOH, ﬂow-rate: 1 mL min
1, inj. vol.: 5 mL of 1 mmol L1 solution, DAD detection at 240 or 260 nm.
This journal is ª The Royal Society of Chemistry 2013 Anal. Methods, 2013, 5, 3122–3128 | 3125
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the better sorbent for the drug. This is attributed to the pres-
ence of the drug itself in the pre-polymerisation mixture,
producing binding sites of superior complementarity to
the targeted structure, but also to the higher ratio of
MAA : template, potentially resulting in more points of attach-
ment for the drug, although the majority of them are of a non-
specic nature, as demonstrated by the longer retention times
exhibited by IMQ-NIP.
Frontal chromatography was performed using 9IBA as the
test analyte on its corresponding imprinted and non-imprinted
polymers; the quantity of the analyte required for the analysis
and the price as well as toxicity of IMQ prohibited its use in such
experiments. In spite of this, when a 9IBA rebinding experiment
was attempted in the low concentration range using IMQ-MIP as
the stationary phase, elution times of each step were excessive
and did not permit accurate collection of experimental points.
The obtained results revealed the superior binding perfor-
mance of 9IBA-MIP versus its non-imprinted counterpart
(Fig. 3). In order to calculate the corresponding binding
isotherms and binding capacities, each isotherm was tted
using the most common binding models used to model similar
materials, namely the single binding site model (Langmuir),
two-binding site model (Bi-Langmuir), the continuous distri-
bution model (Freundlich)20 and the Langmuir–Freundlich
model.21 The obtained results are reported in Table 3 together
with the corresponding sums of least squares (R2) for each
model, as a measure of t quality.
The Langmuir model provides a poor t in the case of 9IBA-
MIP, not unexpectedly, given the well documented heteroge-
neous character of imprinted polymers. The best t is achieved
when the Bi-Langmuir model is applied, assuming a strong and
a weak family of binding sites with aﬃnity constants of 2.3 
104 L mol1 and 0.5  103 L mol1 and a calculated population
of 38.9 mmol g1 and 142.6 mmol g1 respectively. The Freund-
lich and Langmuir–Freundlich models also oﬀer good ttings
of the experimental data, with the former yielding average
parameters closer to the “stronger” sites predicted by the Bi-
Langmuir model and the latter closer to the “weaker” sites.
Although it is conceivable that there are more than just two
types of binding sites in the matrix of the imprinted polymer, a
combination of the above information provides an accurate
representation of the aﬃnity characteristics of the polymer.
In the case of 9IBA-NIP, the Langmuir and Langmuir–
Freundlichmodels yield nearly identical values of average aﬃnity
constant and number of binding sites, while the same parame-
ters are calculated for the “weak” sites using the Bi-Langmuir
model, which constitute the majority of sites in the polymer. The
Freundlichmodel does not oﬀer as good a t, and the parameters
derived are not comparable with the other models. Overall, it
appears that 9IBA-MIP possesses high energy and low energy
sites, the latter being larger in population and with an aﬃnity
constant comparable to the low energy sites of the non-imprinted
counterpart. This indicates that the low energy, or non-specic,
binding sites are of similar nature in both polymers.
3.4 Solid phase extractions
The performance of the template analogue and the directly
imprinted polymers was nally evaluated as SPE sorbents for the
extraction of imiquimod from aqueous samples, urine and blood
serum. Following loading of 1 mL of sample, the cartridges were
washed with 1mLH2O in order to remove any hydrophilic matrix
substances adsorbed onto the polymer. In early experiments, an
attempt was made to elute the cartridges using CH3CN–1%
CH3COOH however the average recovery on the imprinted poly-
mers was less than 10% while up to 40% of the drug was recov-
ered on the non-imprinted polymers. This is in agreement with
Table 3 Aﬃnity constants (Ka), number of binding sites (N) and sum of least squares (R
2) for diﬀerent binding models, calculated from frontal chromatography results
presented in Fig. 3
Binding model
9IBA–MIP 9IBA–NIP
Ka (L mol
1) N (mmol g1) R2 Ka (L mol
1) N (mmol g1) R2
Langmuir 6.0  103 90.8 0.9839 1.8  103 7.7 0.9998
Bi-Langmuir 2.3  104 38.9 0.9996 8.5  105 0.04 0.9999
0.5  103 142.6 1.7  103 7.8
Freundlicha 3.9  104 66.3 0.9919 2.0  104 3.1 0.9918
Langmuir–Freundlichb 1.1  103 162.9 0.9969 1.7  103 8.0 0.9998
a Average Ka and N values calculated from aﬃnity distribution curves.
b Average Ka calculated using Ka ¼ a1/m.
Fig. 3 Frontal chromatography binding isotherms of 9IBA on 9IBA-MIP (A) and
9IBA–NIP (>) packed HPLC columns and the corresponding curves ﬁtted to the
Bi-Langmuir model (dashed lines).
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the chromatographic evaluation results, whereby extremely long
retention times were recorded for IMQ under similar elution
conditions. It was thus decided to use CH3CN–1% CH3COOH in
an intermediate “molecular recognition” step, and employ a
stronger elution solvent mixture to recover IMQ from the
cartridges. Following a series of experiments, CH3OH–5%
CH3COOH was selected and the results obtained using the
optimised protocol are presented in Fig. 4. It should be noted
here that during the initial steps of the optimisation, excessive
template bleeding from IMQ-MIP was observed, which resulted
in recoveries signicantly higher than what was expected for
quantitative recovery of the drug. An extensive wash protocol
using CH3OH–5% CH3COOH was employed and aliquots were
analysed by HPLC until no IMQ could be detected.
Both imprinted polymers achieved high recoveries of the
drug from urine and blood serum samples, albeit IMQ-MIP was
more consistent across the diﬀerent sample matrices and
average recoveries of up to 95% were reached. However, similar
to the observations during chromatographic evaluation, a
signicant amount of non-specically bound IMQ, up to 64.7%,
was recovered from IMQ-NIP, resulting in average imprinting
factors of 1.6. On the other hand, 9IBA-NIP exhibited substan-
tially lower non-specic binding, less than half of what was
measured on IMQ-NIP in some cases, thus imprinting factors
for 9IBA polymers were as high as 4.3 in H2O and 3.3 in urine. It
is noteworthy that both polymers exhibited their lowest recov-
eries and highest imprinting factors in the aqueous samples
while the opposite was observed as sample complexity
increased. The nature and composition of biological samples
appear to “push” the hydrophobic drug onto the polymer
stationary phases, resulting in higher recoveries in blood serum
samples, albeit at the expense of selectivity. Nonetheless, both
materials produced clean extracts as seen in Fig. 5, and no
interference to the quantitation of IMQ was detected.
Thus, it is concluded from this study that 9IBA imprinted
polymers exhibit higher selectivity for IMQ, while possessing a
smaller number of binding sites, resulting in reduced capacity.
The opposite is true for IMQ-MIPs that exhibit marginally
higher capacity but appear to be less specic towards the drug.
4 Conclusions
9-Isobutyladenine was selected as a template analogue for
imiquimod, based on its similar size, shape and functionality
and was synthesised in a 2 step reaction in moderate to high
yields. Pre-polymerisation studies of the complexes formed
between methacrylic acid and the template analogue revealed a
binding constant of 1376  122 M1, higher than those previ-
ously reported, but in agreement with the high aﬃnity exhibited
by the subsequently synthesised imprinted polymers.
Fig. 4 MI-SPE recoveries (%) of imiquimod on (a) 9IBA and (b) IMQ imprinted polymers and the corresponding imprinting factors (dashed lines). Conditions: loading:
1 mL of sample; 1st wash: 1 mL H2O, 2
nd wash: 1 mL CH3CN–1% CH3COOH; elution: 1 mL CH3OH–5% CH3COOH. Blood and urine samples spiked with 10 mg mL
1
imiquimod.
Fig. 5 Typical HPLC chromatograms of the diﬀerent fractions collected by MI-SPE of blood serum samples using (a) 9IBA-MIP and (b) IMQ-MIP. From the bottom, 1st
wash (H2O), 2
nd wash (CH3CN–1% CH3COOH), eluted sample (CH3OH–5% CH3COOH).
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Limitations posed by imiquimod's insolubility were overcome
by using a higher ratio of functional monomer to template and
imiquimod imprinted polymers were synthesised. Chromato-
graphic evaluation of the synthesised polymers revealed longer
retention times for IMQ and related substances on IMQ-MIP
compared to 9IBA-MIP, however the corresponding non-
imprinted polymer exhibited signicant non-specic binding,
resulting in overall reduced imprinting factors. Analysis of
9IBA-MIP and 9IBA-NIP by frontal chromatography demon-
strated the superior binding aﬃnity and capacity of the
imprinted polymers, while the “weak” binding sites of MIP and
NIP were found to have comparable binding energies. When
employed as a SPE sorbent, IMQ-MIP showed the highest
recovery for the drug in biological samples, however high levels
of non-specic binding were found on the corresponding NIP.
9IBA–MIP was capable of achieving marginally lower recoveries
in the same samples however non-specic binding was signi-
cantly lower and overall higher imprinting factors were
calculated.
Based on the above observations on polymer performance,
and considering the clear advantages of 9IBA compared to
imiquimod in terms of solubility, availability, toxicity and cost,
as well as the extensive polymer pre-conditioning required to
eliminate template bleeding, 9IBA is proposed as an excellent
template analogue and its use is fully justied by the experi-
mental results acquired in this study.
Acknowledgements
Financial support from Enterprise Ireland's Applied Research
Enhancement Programme (Contract number: RE-2008-11) and
donation of imiquimod from EirGen Pharma are gratefully
acknowledged.
References
1 Molecularly imprinted polymers. Man made mimics of
antibodies and their applications in analytical chemistry, ed.
B. Sellergren, Elsevier Science B.V., Amsterdam, 2001.
2 C. Alexander, H. S. Andersson, L. I. Andersson, R. J. Ansell,
N. Kirsch, I. A. Nicholls, J. O'Mahony and
M. J. Whitcombe, J. Mol. Recognit., 2006, 19, 106–180.
3 P. Manesiotis and G. Theodoridis, in Encyclopedia of
Chromatography, ed. J. Cazes, Taylor & Francis, 3rd edn,
2009, pp. 24–30.
4 M. Lasakova and P. Jandera, J. Sep. Sci., 2009, 32, 799–812.
5 P. Manesiotis, Q. Osmani and P. McLoughlin, J. Mater.
Chem., 2012, 22, 11201–11207.
6 K. Haupt and K. Mosbach, Chem. Rev., 2000, 100, 2495–
2504.
7 P. Manesiotis, C. Borrelli, C. S. A. Aureliano, C. Svensson and
B. Sellergren, J. Mater. Chem., 2009, 19, 6185–6193.
8 P. Manesiotis, A. Hall, J. Courtois, K. Irgum and
B. Sellergren, Angew. Chem., Int. Ed., 2005, 44, 3902–3906.
9 G. Theodoridis, A. Kantifes, P. Manesiotis, N. Raikos and
H. Tsoukali-Papadopoulou, J. Chromatogr., A, 2003, 987,
103–109.
10 D. A. Spivak, M. A. Gilmore and K. J. Shea, J. Am. Chem. Soc.,
1997, 119, 4388–4393.
11 D. A. Spivak and K. J. Shea, Macromolecules, 1998, 31, 2160–
2165.
12 D. A. Spivak and K. J. Shea, Anal. Chim. Acta, 2001, 435, 65–
74.
13 C. Hanger, J. Dalrymple and D. Hepburn, N. Z. Med. J., 2005,
118, 1682.
14 S. Adams, L. Kozhaya, F. Martiniuk, T. C. Meng,
L. Chiriboga, L. Liebes, T. Hochman, N. Shuman,
D. Axelrod, J. Speyer, Y. Novik, A. Tiersten, J. D. Goldberg,
S. C. Formenti, N. Bhardwaj, D. Unutmaz and S. Demaria,
Clin. Cancer Res., 2012, 18, 6748–6757.
15 Synthetic Procedures in Nucleic Acid Chemistry, ed. W. W.
Zorbach and R. S. Tipson, Interscience, New York, 1968.
16 K. A. Connors, Binding constants; The measurement of
molecular complex stability, John Wiley & Sons, New York,
1987.
17 G. Lancelot, J. Am. Chem. Soc., 1977, 99, 7037–7042.
18 E. M. B. Janke, H.-H. Limbach and K. Weisz, J. Am. Chem.
Soc., 2003, 126, 2135–2141.
19 K. J. Shea, D. A. Spivak and B. Sellergren, J. Am. Chem. Soc.,
1993, 115, 3368–3369.
20 R. J. Umpleby, S. C. Baxter, M. Bode, J. K. Berch, R. N. Shah
and K. D. Shimizu, Anal. Chim. Acta, 2001, 435, 35–42.
21 R. J. Umpleby, S. C. Baxter, Y. Z. Chen, R. N. Shah and
K. D. Shimizu, Anal. Chem., 2001, 73, 4584–4591.
3128 | Anal. Methods, 2013, 5, 3122–3128 This journal is ª The Royal Society of Chemistry 2013
Analytical Methods Paper
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
3 
A
pr
il 
20
13
. D
ow
nl
oa
de
d 
on
 0
3/
10
/2
01
5 
11
:0
3:
36
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
